666 related articles for article (PubMed ID: 22112477)
1. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
3. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
4. Beyond grade: molecular pathology of malignant gliomas.
Sulman EP; Guerrero M; Aldape K
Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
[TBL] [Abstract][Full Text] [Related]
5. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
6. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
7. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
8. Liver grafts from donors with central nervous system tumors: a single-center perspective.
Kashyap R; Ryan C; Sharma R; Maloo MK; Safadjou S; Graham M; Tretheway D; Jain A; Orloff M
Liver Transpl; 2009 Oct; 15(10):1204-8. PubMed ID: 19790151
[TBL] [Abstract][Full Text] [Related]
9. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
10. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
11. Genetics, prognosis and therapy of central nervous system tumors.
Watkins D; Rouleau GA
Cancer Detect Prev; 1994; 18(2):139-44. PubMed ID: 8025896
[TBL] [Abstract][Full Text] [Related]
12. The prostate stem cell antigen represents a novel glioma-associated antigen.
Geiger KD; Hendruschk S; Rieber EP; Morgenroth A; Weigle B; Juratli T; Senner V; Schackert G; Temme A
Oncol Rep; 2011 Jul; 26(1):13-21. PubMed ID: 21503583
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
14. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
Fontebasso AM; Bechet D; Jabado N
Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
[TBL] [Abstract][Full Text] [Related]
15. Sensory and motor deficits of central nervous system origin.
Aravabhumi S; Izzo KL
Clin Podiatr Med Surg; 1989 Oct; 6(4):707-43. PubMed ID: 2680039
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy.
Florian IS; Tomuleasa C; Soritau O; Timis T; Ioani H; Irimie A; Kacso G
J BUON; 2011; 16(1):16-23. PubMed ID: 21674845
[TBL] [Abstract][Full Text] [Related]
18. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R;
Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370
[TBL] [Abstract][Full Text] [Related]
19. Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Probst-Cousin S; Rickert CH; Gullotta F
Clin Neuropathol; 1998; 17(2):79-84. PubMed ID: 9561329
[TBL] [Abstract][Full Text] [Related]
20. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity.
Amberger VR; Hensel T; Ogata N; Schwab ME
Cancer Res; 1998 Jan; 58(1):149-58. PubMed ID: 9426071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
